Gilenya Safety Review Hits Sales
Gilenya Safety Review. Eleven deaths among people taking the multiple sclerosis drug Gilenya have caused it to lose market share since it hit the U.S. market in late-2010. According to a Bloomberg report, Gilenya’s share of the market for immunomodulatory drugs used in the treatment of MS from from 6.2 percent to 6.1 in … [Read more...]
Loryna in Blood Clot Safety Review
Loryna Blood Clot Safety Review. Loryna, a generic form of Yaz recently approved by the U.S. Food & Drug Administration (FDA), may put women at risk for a higher risk of blood clots. Just weeks after the FDA approved the medication, the agency announced it was reviewing Loryna, along with Yaz, Yasmin and several other similar … [Read more...]
Yaz, Yasmin Blood Clot Fears Spark Canadian Safety Review
Yaz, Yasmin Risk Of Blood Clots. Two studies published this year in the British Medical Journal have prompted Canadian regulators to launch a safety review of Yaz and Yasmin. The aim of the review is to determine if Bayer Corporation's popular birth control pills pose a higher risk of blood clots compared to pills made with a … [Read more...]
Diet Pills May Be Causing Liver Damage
Diet Pills Causing Liver Damage. The fat absorption inhibiting diet pill, Alli, is being investigated over concerns that it is associated with liver damage. According to the Daily Mail, Alli is the first such diet pill to be available to consumers without a prescription. Earlier last month we wrote that drugs containing orlistat … [Read more...]
Singulair Safety Review
Singulair Safety Review. Federal regulators said today that they are continuing a probe into the psychiatric side effects of Singulair and similar asthma drugs. The Food & Drug Administration (FDA) began looking into the drugs' potential psychiatric side effects last March, after it received several reports of suicidal behavior in … [Read more...]
FDA Taking Another Look at Chantix
FDA Safety Review Of Chantix. The release of a Chantix study last week that linked the drug to numerous side effects has prompted the Food & Drug Administration (FDA) to initiate another safety review of the drug. The review will mark the second such investigation for Chantix, which is already being scrutinized because of its … [Read more...]
Regranex Link to Cancer Deaths Investigation
Regranex Link to Cancer Deaths. Regranex, a gel used by diabetics to treat leg and foot wounds, has been linked to an increased incidence of cancer and deaths, prompting the Food & Drug Administration (FDA) to announce a Regranex safety review. Regranex, manufactured by Johnson & Johnson, is a topical medicine … [Read more...]
FDA Seeks Info As Part of Safety Review
Safety Review on Serevent, Advair, Foradil. Asthma drugs, including Serevent, Advair, Foradil, are the subject of a Food & Drug Administration (FDA) safety review. The FDA has requested information from the manufacturers of the asthma medications as part of an ongoing safety review of the drugs in children. Serevent, Advair … [Read more...]
